Table 2—

Indicators of lipid and glucose metabolism according to HRT in diabetic postmenopausal women aged 40–74 years: NHANES III, 1988–1994

HRT use status in diabetes
Current
Previous
Never
Sample size*Mean (95% CI)Sample size*Mean (95% CI)Sample size*Mean (95% CI)
Total cholesterol (mg/dl)83225 (217–233)178247 (238–256)524241 (235–246)
HDL (mg/dl)8256 (50–62)17552 (49–56)51651 (48–53)
Non-HDL (mg/dl)82169 (158–180)175192 (182–201)516188 (182–194)
Total cholesterol-to-HDL ratio824.40 (3.85–4.94)1755.09 (4.69–5.49)5165.15 (4.89–5.39)
Triglycerides (mg/dl)83219 (167–270)177249 (194–304)524224 (201–246)
Lp(a) (mg/dl)5422 (10–33)9224 (15–32)28922 (17–27)
ApoA (mg/dl)29171 (158–185)84151 (142–161)232147 (143–150)
ApoB (mg/dl)29117 (109–125)85135 (127–143)234125 (120–130)
Fibrinogen (mg/dl)82306 (285–327)172336 (309–363)515342 (331–353)
C-reactive protein (mg/dl)820.97 (0.58–1.35)1770.66 (0.48–0.83)5220.84 (0.70–0.98)
Fasting glucose (mg/dl)83112 (104–120)180151 (137–166)528154 (141–166)
Fasting insulin (μU/ml)8216.7 (13.4–20.1)17820.6 (16.5–24.7)52322.6 (19.4–25.8)
GHb (mg/dl)846.03 (5.70–6.35)1806.91 (6.46–7.36)5257.13 (6.81–7.44)
  • *

    * Unweighted sample sizes.